Cargando…

The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial

Background: Reducing vaccine wastage is important. Bacille Calmette-Guérin (BCG) vaccine is produced in vials of 20 infant doses. The reconstituted vaccine is discarded after 4–6 hours. Therefore, to reduce vaccine wastage, a 20-dose vial of BCG is often only opened if at least 10–12 infants are pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaltz-Buchholzer, Frederik, Frankel, Hannah Nørtoft, Benn, Christine Stabell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328326/
https://www.ncbi.nlm.nih.gov/pubmed/28169606
http://dx.doi.org/10.1080/16549716.2017.1267964
_version_ 1782510885787402240
author Schaltz-Buchholzer, Frederik
Frankel, Hannah Nørtoft
Benn, Christine Stabell
author_facet Schaltz-Buchholzer, Frederik
Frankel, Hannah Nørtoft
Benn, Christine Stabell
author_sort Schaltz-Buchholzer, Frederik
collection PubMed
description Background: Reducing vaccine wastage is important. Bacille Calmette-Guérin (BCG) vaccine is produced in vials of 20 infant doses. The reconstituted vaccine is discarded after 4–6 hours. Therefore, to reduce vaccine wastage, a 20-dose vial of BCG is often only opened if at least 10–12 infants are present, jeopardising BCG vaccination coverage and timely vaccination. We observed that nurses were not able to withdraw 20 doses from the vials and aimed to quantify how many doses could be obtained from these vials by experienced nurses under real-life circumstances. Methods: At the maternity ward of the national hospital in Guinea-Bissau, since 2002 the same two nurses have been vaccinating all eligible children with BCG before discharge. During a month in 2015, within a randomised trial comparing BCG-Denmark and BCG-Russia, we registered how many doses the nurses were able to withdraw from the two types of vaccine vials. Results: The median number of doses which it was possible to withdraw from the vials was 13 (range 11–17): 13 (11–16) for BCG-Denmark (based on 39 vials) and 15 (12–17) for BCG-Russia (based on 29 vials). Conclusions: In real life, experienced nurses could only obtain 13–15 doses from the 20-dose vials. Thus, vaccine wastage is much lower than assumed. Adjusting practice to the real-life number of doses would immediately suggest vials should be opened if 7 rather than 10 infants are present. As other studies have indicated that BCG may have beneficial non-specific effects on overall mortality, the potential gain by opening a 20-dose vial even for one child may be considerable.
format Online
Article
Text
id pubmed-5328326
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-53283262017-03-06 The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial Schaltz-Buchholzer, Frederik Frankel, Hannah Nørtoft Benn, Christine Stabell Glob Health Action Short Communication Background: Reducing vaccine wastage is important. Bacille Calmette-Guérin (BCG) vaccine is produced in vials of 20 infant doses. The reconstituted vaccine is discarded after 4–6 hours. Therefore, to reduce vaccine wastage, a 20-dose vial of BCG is often only opened if at least 10–12 infants are present, jeopardising BCG vaccination coverage and timely vaccination. We observed that nurses were not able to withdraw 20 doses from the vials and aimed to quantify how many doses could be obtained from these vials by experienced nurses under real-life circumstances. Methods: At the maternity ward of the national hospital in Guinea-Bissau, since 2002 the same two nurses have been vaccinating all eligible children with BCG before discharge. During a month in 2015, within a randomised trial comparing BCG-Denmark and BCG-Russia, we registered how many doses the nurses were able to withdraw from the two types of vaccine vials. Results: The median number of doses which it was possible to withdraw from the vials was 13 (range 11–17): 13 (11–16) for BCG-Denmark (based on 39 vials) and 15 (12–17) for BCG-Russia (based on 29 vials). Conclusions: In real life, experienced nurses could only obtain 13–15 doses from the 20-dose vials. Thus, vaccine wastage is much lower than assumed. Adjusting practice to the real-life number of doses would immediately suggest vials should be opened if 7 rather than 10 infants are present. As other studies have indicated that BCG may have beneficial non-specific effects on overall mortality, the potential gain by opening a 20-dose vial even for one child may be considerable. Taylor & Francis 2017-01-27 /pmc/articles/PMC5328326/ /pubmed/28169606 http://dx.doi.org/10.1080/16549716.2017.1267964 Text en © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Schaltz-Buchholzer, Frederik
Frankel, Hannah Nørtoft
Benn, Christine Stabell
The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial
title The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial
title_full The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial
title_fullStr The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial
title_full_unstemmed The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial
title_short The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial
title_sort real-life number of neonatal doses of bacille calmette-guérin vaccine in a 20-dose vial
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328326/
https://www.ncbi.nlm.nih.gov/pubmed/28169606
http://dx.doi.org/10.1080/16549716.2017.1267964
work_keys_str_mv AT schaltzbuchholzerfrederik thereallifenumberofneonataldosesofbacillecalmetteguerinvaccineina20dosevial
AT frankelhannahnørtoft thereallifenumberofneonataldosesofbacillecalmetteguerinvaccineina20dosevial
AT bennchristinestabell thereallifenumberofneonataldosesofbacillecalmetteguerinvaccineina20dosevial
AT schaltzbuchholzerfrederik reallifenumberofneonataldosesofbacillecalmetteguerinvaccineina20dosevial
AT frankelhannahnørtoft reallifenumberofneonataldosesofbacillecalmetteguerinvaccineina20dosevial
AT bennchristinestabell reallifenumberofneonataldosesofbacillecalmetteguerinvaccineina20dosevial